AnteoTech Receives $185,000 Order from Serum Institute of India, Shares Jump 12%

MT Newswires Live

Dec 29, 2025

AnteoTech (ASX:ADO) received an order from the Serum Institute of India for $185,000 on Dec. 24, in line with the five-year supply agreement between the parties, according to a Monday Australian bourse filing.

The order will be dispatched on Jan. 5, 2026. It will also provide prototypes of a new AnteoBind activated enzyme-linked immunosorbent assay plate product, currently under development, to the Serum Institute of India.

It also secured new sales to Japanese customers of around AU$70,000, and it is working on the appointment of a new distributor in Japan.

Its shares jumped 12% in recent trading on Monday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2595205589"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595205589\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595205589?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-29 11:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595205589","market":"fut","top_or_hot":-1,"title":"AnteoTech Receives $185,000 Order from Serum Institute of India, Shares Jump 12%","media":"MT Newswires Live","content":"<html><body><p> AnteoTech (ASX:ADO) received an order from the Serum Institute of India for $185,000 on Dec. 24, in line with the five-year supply agreement between the parties, according to a Monday Australian bourse filing.</p><p>The order will be dispatched on Jan. 5, 2026. It will also provide prototypes of a new AnteoBind activated enzyme-linked immunosorbent assay plate product, currently under development, to the Serum Institute of India.</p><p>It also secured new sales to Japanese customers of around AU$70,000, and it is working on the appointment of a new distributor in Japan.</p><p>Its shares jumped 12% in recent trading on Monday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AnteoTech Receives $185,000 Order from Serum Institute of India, Shares Jump 12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnteoTech Receives $185,000 Order from Serum Institute of India, Shares Jump 12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-29 11:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> AnteoTech (ASX:ADO) received an order from the Serum Institute of India for $185,000 on Dec. 24, in line with the five-year supply agreement between the parties, according to a Monday Australian bourse filing.</p><p>The order will be dispatched on Jan. 5, 2026. It will also provide prototypes of a new AnteoBind activated enzyme-linked immunosorbent assay plate product, currently under development, to the Serum Institute of India.</p><p>It also secured new sales to Japanese customers of around AU$70,000, and it is working on the appointment of a new distributor in Japan.</p><p>Its shares jumped 12% in recent trading on Monday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADO.AU","symbol_name":"AnteoTech Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2595205589","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595205589","pubTimestamp":1766977934,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"AnteoTech  received an order from the Serum Institute of India for $185,000 on Dec. 24, in line with the five-year supply agreement between the parties, according to a Monday Australian bourse filing.The order will be dispatched on Jan. 5, 2026. It will also provide prototypes of a new AnteoBind activated enzyme-linked immunosorbent assay plate product, currently under development, to the Serum Institute of India.It also secured new sales to Japanese customers of around AU$70,000, and it is working on the appointment of a new distributor in Japan.Its shares jumped 12% in recent trading on Monday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ADO.AU":"AnteoTech Ltd","BK7036":"特种化学制品","BK7048":"生命科学工具和服务","BK7508":"医药生物股","BK7501":"新冠治疗股"},"translate_title":"AnteoTech收到印度血清研究所185,000美元订单，股价上涨12%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADO.AU":1,"MNDmain":1.5},"content_text":"AnteoTech (ASX:ADO) received an order from the Serum Institute of India for $185,000 on Dec. 24, in line with the five-year supply agreement between the parties, according to a Monday Australian bourse filing.The order will be dispatched on Jan. 5, 2026. It will also provide prototypes of a new AnteoBind activated enzyme-linked immunosorbent assay plate product, currently under development, to the Serum Institute of India.It also secured new sales to Japanese customers of around AU$70,000, and it is working on the appointment of a new distributor in Japan.Its shares jumped 12% in recent trading on Monday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}